SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-22-006607
Filing Date
2022-05-12
Accepted
2022-05-12 17:01:01
Documents
54
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ndra_10q.htm   iXBRL 10-Q 596517
2 EX-31.1 ndra_ex311.htm EX-31.1 10137
3 EX-31.2 ndra_ex312.htm EX-31.2 9803
4 EX-32.1 ndra_ex321.htm EX-32.1 4391
  Complete submission text file 0001654954-22-006607.txt   3132371

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ndra-20220331.xsd EX-101.SCH 39597
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndra-20220331_lab.xml EX-101.LAB 242589
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ndra-20220331_cal.xml EX-101.CAL 36650
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndra-20220331_pre.xml EX-101.PRE 194787
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ndra-20220331_def.xml EX-101.DEF 104148
48 EXTRACTED XBRL INSTANCE DOCUMENT ndra_10q_htm.xml XML 353425
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37969 | Film No.: 22918798
SIC: 3845 Electromedical & Electrotherapeutic Apparatus